Circulating microRNAs predict the response to anti-PD-1 therapy in non-small cell lung cancer.

In conclusion, these results demonstrated that alterations in circulating miRNAs are associated with the response and outcome in NSCLC patients treated with anti-PD1 drugs.
PMID: 31786291 [PubMed - as supplied by publisher]

Source: Genomics - November 27, 2019 Category: Genetics & Stem Cells Authors: Fan J, Yin Z, Xu J, Wu F, Huang Q, Yang L, Jin Y, Yang G Tags: Genomics Source Type: research